Michael Sidler

Michael Sidler is a highly experienced venture capitalist, co-founding Redalpine Venture Partners in 2006 and serving as a General Partner. He focuses on seed to Series A investments in high-tech companies across ICT and Life Sciences, including AI, health tech, and synthetic biology, with a systematic approach to identifying promising startups. lifeboat+3

With a background as a Plant Molecular Biologist from the University of Zurich, Michael uniquely blends scientific rigor with entrepreneurial intuition. His career trajectory from a lab researcher to a consultant at The Boston Consulting Group, and then to a venture capitalist, highlights his ability to bridge science, technology, entrepreneurship, and finance. lifeboat+4

He possesses extensive board experience, advising and sitting on the boards of numerous biotech and healthtech ventures such as Araris Biotech AG, Apoha, ExpressionEdits, Better Dairy, Aktiia, ImmunOs Therapeutics, and Memo Therapeutics. This demonstrates his deep engagement and commitment to fostering innovation in the life sciences sector. lifeboat+2

Michael is a strong advocate for the Swiss startup ecosystem, having chaired the Seed and Venture Capital Chapter at SECA and served on the board of Swiss Startup Invest. He has observed and contributed to the cultural shift in Switzerland, where founding a startup has transformed from a fallback option to a respected career path. lifeboat+2